The author discusses the impact of prefilled syringe product contact materials and the filling and stoppering process on protein aggregates.
Wendy Saffell-Clemmer
Advertisement
Wendy Saffell-Clemmer, BPS, is research director, R&D and innovation, at Baxter Healthcare.
Articles by Wendy Saffell-Clemmer
Contract manufacturers must plan for increased analytical resources in development and quality control.
Advertisement
Latest Updated Articles
A Case Study of Developing Analytical MethodsPublished: April 1st 2005 | Updated:
Impact of PFS and Filling Process Selection on Biologic Product StabilityPublished: April 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
2
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
3
Welcome to CPHI Frankfurt 2025
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
